News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...

Recent Postings



Dendreon (DNDN) Array Pharmaceuticals (ARRY) Sangamo (SGMO) Valeant Pharmaceuticals International (VRX) Revlimid (lenolidamide) Agenus (AGEN) Theravance Bio Pharma (TBPH) Rapamune Bristol-Myers Squibb (BMY) C4 Therapeutics KITE (KITE) ACADIA (ACAD) TOKAI (TKAOI) OSI (OSIP) NEKTAR (NKTR)) Dynavax (DVAX) Xoma (XOMA) NANTKWEST (NK) ZALTRAP™ ISIS (ISIS) Sanofi (SNY) Auspex (ASPX) Intercept (ICPT) Tysabri Abbott Laboratories (ABT) Theravance (THRX) Vertex (VRTX) Trastuzumab-DM1 Zerenex Multiple Myeloma Ionis (IONS) Ridaforolimus PTC Therapeutics (PTCT) Galena (GALE) Endometrial Cancer Sanofi (SNA) Pluristem (PSTI) ImmunoGen (IMGN) Seattle Genetics (SGEN) Velcade (bortezomib) Vitae Pharmaceuticals (VTAE) Aimmune Therapeutics (AIMT) Exelixis (EXEL) Sequenom (SQNM) SUNESIS PHARMACEUTICALS (SNSS) Cytokinetics (CYTK) Jazz Pharmaceuticals (JAZZ) Sarepta (SRPT) Regeneron (REGN) Idenix (IDIX) galapagos (GLPG) CompuGen (CGEN) SERES THERAPEUTICS (MCRB) Anacor (ANAC) Anadys (ANDS) Sanofi-Aventis (SAN) AERIE PHARMACEUTICALS ABBVIE (ABBV) Agenus (AGEN Gilead (GILD) GlaxoSmithKline (GSK) Roche (ROCHE) Prosensa (RNA) Biogen Idec (BIIB) REGULUS (RGLS) Inovio (INO) Incyte (INCY) Intermune (ITMN) Telaprevir Benlysta (belimumab) Editas (EDIT) Alnylam (ALNY) HALOZYME (HALO) Biocryst (BCRX) Onyx (ONXX) Micromet (MITI) Genentech RenenxBio (RGNX) KERYX (KERX) Illumina (ILMN) Amgen (AMGN) VANDA (VNDA) ADVENTRIX (ANX) IDERA (IDRA) Merck (MRK) Ziofpharm (ZIOP) Mirati Therapeutics (MRTX) Ariad (ARIA) Intrexon (XON) Roche (RHHBY) ARCA (ABIO) Elan (ELN) Prolor Biotech (PBTH) Herceptin GUARDIAN HEALTH SYNTA (SNTA) Human Genome Sciences (HGSI) BIOMARIN (BMRN) Human Longevity (HLI) Alder Biopharmaceuticals (ALDR) JUNO (JUNO)